High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR‐SS Technology for Monitoring Advanced Urothelial Carcinoma
ABSTRACT Advanced urothelial carcinoma (aUC) has a poor prognosis, and real‐time monitoring of treatment response remains clinically challenging. Circulating tumor DNA (ctDNA) has emerged as a promising non‐invasive biomarker that may reflect tumor burden and molecular response. In this study, we an...
Gardado en:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2026-06-01
|
| Series: | Cancer Medicine |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/cam4.72045 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
